Clinical and Experimental Hypertension最新文献

筛选
英文 中文
Blood Pressure and Blood Glucose Responses to Combined Exercise Sessions of Different Intensities in Individuals with Cardiovascular Risk Factors 有心血管危险因素个体不同强度联合运动对血压和血糖的反应
IF 12.3 4区 医学
Clinical and Experimental Hypertension Pub Date : 2022-04-14 DOI: 10.1080/10641963.2022.2065289
Mabel Diesel, Isabel Heberle, G. Juchem, Guilherme Tadeu de Barcelos, Juliana Cavestré Coneglian, A. Gerage, R. S. Delevatti
{"title":"Blood Pressure and Blood Glucose Responses to Combined Exercise Sessions of Different Intensities in Individuals with Cardiovascular Risk Factors","authors":"Mabel Diesel, Isabel Heberle, G. Juchem, Guilherme Tadeu de Barcelos, Juliana Cavestré Coneglian, A. Gerage, R. S. Delevatti","doi":"10.1080/10641963.2022.2065289","DOIUrl":"https://doi.org/10.1080/10641963.2022.2065289","url":null,"abstract":"ABSTRACT Objective The purpose of the present study was to verify the acute effects of blood pressure and blood glucose after two sessions of combined exercise sessions performed at two levels of intensity in trained individuals with cardiovascular risk factors. Methods Eighteen individuals (66.22 ± 8.61 years) of both sexes (6 women/12 men) with cardiovascular risk factors performed two sessions of combined exercises at different levels of intensity: moderate (MOD) and high (HI). To control the intensity of the aerobic training, the Borg Rating of Perceived Exertion (RPE) Scale was used. For the strength training, the maximum number of repetitions was carried out within a predetermined duration of sets. Blood pressure and blood glucose measurements were collected before and 20 minutes after the sessions. The data were analyzed using Generalized Estimating Equations, α 5%. Results Reductions were observed in systolic blood pressure (MOD – Δ = −4.95 mmHg; HI – Δ = −3.31 mmHg) and blood glucose (MOD – Δ = −16.06 mg/dL; HI – Δ = −29.45 mg/dL) after the two sessions, with no difference between sessions. Diastolic blood pressure did not change (p < .05). Conclusion Combined exercises sessions of moderate or high intensity can promote an acute reduction in systolic blood pressure and glycemia in individuals with cardiovascular risk factors.","PeriodicalId":10333,"journal":{"name":"Clinical and Experimental Hypertension","volume":"18 1","pages":"436 - 441"},"PeriodicalIF":12.3,"publicationDate":"2022-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84959219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inter-arm blood pressure difference is associated with contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention. st段抬高型心肌梗死患者行原发性经皮冠状动脉介入治疗后,臂间血压差与造影剂肾病相关。
IF 12.3 4区 医学
Clinical and Experimental Hypertension Pub Date : 2022-04-03 Epub Date: 2022-01-21 DOI: 10.1080/10641963.2022.2029471
Zeki Simsek, Regayip Zehir, Sedat Kalkan, Doğancan Ceneli, Elnur Alizade, Emrah Bayam, Özkan Candan
{"title":"Inter-arm blood pressure difference is associated with contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention.","authors":"Zeki Simsek,&nbsp;Regayip Zehir,&nbsp;Sedat Kalkan,&nbsp;Doğancan Ceneli,&nbsp;Elnur Alizade,&nbsp;Emrah Bayam,&nbsp;Özkan Candan","doi":"10.1080/10641963.2022.2029471","DOIUrl":"https://doi.org/10.1080/10641963.2022.2029471","url":null,"abstract":"<p><strong>Objective: </strong>Contrast-induced nephropathy (CIN) is a serious complication in patients with ST segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (p-PCI). An interarm systolic blood pressure difference (IASBD) ≥10 mmHg has been identified as an independent risk factor for cardiovascular disease and mortality. The aim of this study was to evaluate the predictive value of the IASBD for the risk of CIN in patients with STEMI who underwent p-PCI.</p><p><strong>Method: </strong>We prospectively investigated 2120 consecutive patients who were hospitalized with a diagnosis of STEMI and underwent p-PCI. A relative increase in serum creatinine levels of ≥ 25% or an absolute increase of ≥ 0.5 mg/dL from baseline within 72 h of contrast exposure was defined as CIN. The IASBD was calculated on admission to the emergency department. The risk of CIN was evaluated.</p><p><strong>Results: </strong>The incidence of CIN was 6.6% (n = 139). The patients were divided into 2 groups based on the development of CIN. Age (p = .001), baseline creatinine levels (p < .001), DM (p < .001), HT (p < .001) and anemia (p = .001) were higher in patients with CIN. An IASBD ≥10 mmHg was noted in 13 (9.3%) patients in the CIN group and 83 (4.1%) (p = .001) in the non-CIN group (Table 1). According to the multivariate analysis, the IASBD was found to be a predictor of CIN development (OR: 2.36, 95% CI: 1.42-3.90, p: 0.001).</p><p><strong>Conclusion: </strong>The IASBD on admission can be a potential predictor of CIN development in patients with STEMI who underwent p-PCI.</p>","PeriodicalId":10333,"journal":{"name":"Clinical and Experimental Hypertension","volume":"44 3","pages":"258-262"},"PeriodicalIF":12.3,"publicationDate":"2022-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39707008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiovascular protective effect of nano selenium in hypothyroid rats: protection against oxidative stress and cardiac fibrosis. 纳米硒对甲状腺功能减退大鼠的心血管保护作用:对氧化应激和心脏纤维化的保护作用。
IF 12.3 4区 医学
Clinical and Experimental Hypertension Pub Date : 2022-04-03 Epub Date: 2022-02-10 DOI: 10.1080/10641963.2022.2036994
Seyed Hamidreza Rastegar Moghaddam, Mahmoud Hosseini, Fereshteh Sabzi, Fatemeh Hojjati Fard, Narges Marefati, Farimah Beheshti, Majid Darroudi, Alireza Ebrahimzadeh Bideskan, Akbar Anaeigoudari
{"title":"Cardiovascular protective effect of nano selenium in hypothyroid rats: protection against oxidative stress and cardiac fibrosis.","authors":"Seyed Hamidreza Rastegar Moghaddam,&nbsp;Mahmoud Hosseini,&nbsp;Fereshteh Sabzi,&nbsp;Fatemeh Hojjati Fard,&nbsp;Narges Marefati,&nbsp;Farimah Beheshti,&nbsp;Majid Darroudi,&nbsp;Alireza Ebrahimzadeh Bideskan,&nbsp;Akbar Anaeigoudari","doi":"10.1080/10641963.2022.2036994","DOIUrl":"https://doi.org/10.1080/10641963.2022.2036994","url":null,"abstract":"<p><strong>Background: </strong>Nano selenium (Nano Sel) has many therapeutic properties including antioxidant, anticancer, and anti-inflammatory actions.</p><p><strong>Objective: </strong>Impacts of Nano Sel administration against cardiac fibrosis and heart and aorta tissue oxidative damage observed in hypothyroid rats were explored.</p><p><strong>Methods: </strong>The animals were randomly grouped and treated as: 1) Control; 2) Propylthiouracil (PTU) in which PTU was added to the drinking water (0.05%) to induce hypothyroidism; 3-5) PTU-Nano Sel 50, PTU-Nano Sel 100, and PTU-Nano Sel 150 groups, which received daily PTU plus 50,100 or 150 µg/kg of Nano Sel for 6 weeks intraperitoneally. The heart and aorta tissues were removed under deep anesthesia and then biochemical parameters including malondialdehyde (MDA), total thiol groups, catalase (CAT), and superoxide dismutase (SOD), as well as cardiac fibrosis were assessed.</p><p><strong>Results: </strong>Hypothyroidism induced by PTU was remarkably associated with myocardial hypertrophy and perivascular fibrosis in Masson's trichrome staining. Moreover, hypothyroidism increased MDA level, while it subtracted total thiol group content and activity of SOD and CAT. Treatment with Nano Sel recovered hypothyroidism-induced cardiac fibrosis in the histological assessment. Nano Sel also promoted CAT and SOD activity and thiol content, whereas alleviated MDA levels in the heart and aorta tissues.</p><p><strong>Conclusion: </strong>Results propose that administration of Nano Sel exerts a protective role in the cardio vascular system via preventing cardiac fibrosis and inhibiting oxidative stress.</p>","PeriodicalId":10333,"journal":{"name":"Clinical and Experimental Hypertension","volume":"44 3","pages":"268-279"},"PeriodicalIF":12.3,"publicationDate":"2022-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39610507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Serum irisin and adropin levels may be predictors for coronary artery ectasia. 血清鸢尾素和促肾上腺素水平可能是冠状动脉扩张的预测因子。
IF 12.3 4区 医学
Clinical and Experimental Hypertension Pub Date : 2022-04-03 Epub Date: 2022-01-07 DOI: 10.1080/10641963.2021.2018601
Bayram Ali Uysal, Mevlut Serdar Kuyumcu
{"title":"Serum irisin and adropin levels may be predictors for coronary artery ectasia.","authors":"Bayram Ali Uysal,&nbsp;Mevlut Serdar Kuyumcu","doi":"10.1080/10641963.2021.2018601","DOIUrl":"https://doi.org/10.1080/10641963.2021.2018601","url":null,"abstract":"<p><strong>Background: </strong>There is strong evidence that oxidative stress and inflammation may contribute to the coronary artery ectasia (CAE) pathophysiology. Recent studies have shown that serum irisin and adropin levels are associated with oxidative stress and inflammation. In the light of this information, we aimed to investigate the possible relationship between serum irisin, adropin levels and CAE.</p><p><strong>Patients & methods: </strong>A total of 50 consecutive patients with CAE and 50 consecutive patients with normal coronary anatomy (NCA) were enrolled into the study. Serum irisin, adropin and other clinical parameters were compared between groups.</p><p><strong>Results: </strong>Adropin (<i>p</i> < .001) and irisin (<i>p</i> < .001) levels were lower in the CAE group. Low adropin (<i>p</i> = .014) and irisin (<i>p</i> < .001) levels were detected as an independent risk factor for CAE in multiple regression analysis. Receiver operating characteristic curve analysis showed that serum adropin (<i>p</i> < .001) and irisin (<i>p</i> < .001) leves was significant predictor of CAE.</p><p><strong>Conclusions: </strong>The results of this study showed that serum irisin and adropin level was lower in the CAE group than in the NCA group. Irisin and adropin could play a role in the pathogenesis of CAE.</p>","PeriodicalId":10333,"journal":{"name":"Clinical and Experimental Hypertension","volume":"44 3","pages":"223-227"},"PeriodicalIF":12.3,"publicationDate":"2022-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39882443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Insertion/deletion polymorphism at angiotensin-converting enzyme gene in PTSD individuals and their reciprocal effects on blood pressure. PTSD患者血管紧张素转换酶基因的插入/缺失多态性及其对血压的影响。
IF 12.3 4区 医学
Clinical and Experimental Hypertension Pub Date : 2022-04-03 Epub Date: 2021-12-22 DOI: 10.1080/10641963.2021.2018598
Ling Nan Kong, Yi Lin Shen, Yong Li Chen, Xu Chen, Guo Ming Su, Jin Hua Wang, Gui Bang Xiao, Qi Wei Guo, Ji Cheng Zhang, Ding Zhi Fang, Jia Lin
{"title":"Insertion/deletion polymorphism at angiotensin-converting enzyme gene in PTSD individuals and their reciprocal effects on blood pressure.","authors":"Ling Nan Kong,&nbsp;Yi Lin Shen,&nbsp;Yong Li Chen,&nbsp;Xu Chen,&nbsp;Guo Ming Su,&nbsp;Jin Hua Wang,&nbsp;Gui Bang Xiao,&nbsp;Qi Wei Guo,&nbsp;Ji Cheng Zhang,&nbsp;Ding Zhi Fang,&nbsp;Jia Lin","doi":"10.1080/10641963.2021.2018598","DOIUrl":"https://doi.org/10.1080/10641963.2021.2018598","url":null,"abstract":"<p><strong>Objectives: </strong>The aim of the present study was to investigate relationships between insertion/deletion (<i>I/D</i>) polymorphism at angiotensin-converting enzyme gene (<i>ACE</i>) and post-traumatic stress disorder (PTSD), as well as their interactions on blood pressure.</p><p><strong>Methods: </strong>Variants of <i>ACE I/D</i> were identified by polymerase chain reaction method and verified by DNA sequencing. PTSD symptoms were assessed by the PTSD Checklist-Civilian Version (PCL-C) based on DSM-IV-TR criteria among high school students at 6 months after the 2008 Wenchuan earthquake.</p><p><strong>Results: </strong>Female subjects were found to have higher prevalence of PTSD and PCL-C scores than male counterparts in the II homozygotes (<i>p</i> = .038 for PTSD and <i>p</i> = .003 for PCL-C scores) and the ID heterozygotes (<i>p</i> = .000 for PTSD and <i>p</i> = .000 for PCL-C scores), but not in the DD homozygotes. Male subjects with the ID (<i>p</i> = .046) or the DD genotype (<i>p</i> = .039) had lower pulse pressure (PP) than the male II homozygotes, while the female II homozygotes had lower diastolic blood pressure (DBP) than the female DD homozygotes (<i>p</i> = .036). <i>ACE I/D</i>, PTSD, or PCL-C scores, as well as gender and BMI, were found to be the predictors of PP.</p><p><strong>Conclusions: </strong>These results indicate that there are interactions of <i>ACE I/D</i> and PTSD, together with gender and BMI, on PP. This finding may be the additional explanation for the heterogeneous relationships between PTSD and blood pressure, and suggest psychiatry care and different medication strategies for patients with comorbidities of PTSD and hypertension and with different genotypes of <i>ACE I/D</i>.</p>","PeriodicalId":10333,"journal":{"name":"Clinical and Experimental Hypertension","volume":"44 3","pages":"208-214"},"PeriodicalIF":12.3,"publicationDate":"2022-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39746097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current prescription status of antihypertensive drugs in Chinese patients with hypertension: analysis by type of comorbidities. 中国高血压患者降压药处方现状:合并症类型分析
IF 12.3 4区 医学
Clinical and Experimental Hypertension Pub Date : 2022-04-03 Epub Date: 2022-01-03 DOI: 10.1080/10641963.2021.2022688
Renren Yang, Jia Tang, Yunping Zhuo, Ming Kuang, Hongying Liu
{"title":"Current prescription status of antihypertensive drugs in Chinese patients with hypertension: analysis by type of comorbidities.","authors":"Renren Yang,&nbsp;Jia Tang,&nbsp;Yunping Zhuo,&nbsp;Ming Kuang,&nbsp;Hongying Liu","doi":"10.1080/10641963.2021.2022688","DOIUrl":"https://doi.org/10.1080/10641963.2021.2022688","url":null,"abstract":"<p><p>In 2020, the National Center for Cardiovascular Diseases with National Committee on Hypertension Management in Primary Health Care in China issued revised national clinical practice guidelines on the management of hypertension in primary health care based on the 2018 Chinese guidelines for the management of hypertension. To evaluate adherence to the guidelines, this retrospective study assessed the real-world status of antihypertensive drug prescribing for Chinese patients with hypertension, classified by comorbidity: coronary heart disease, diabetes mellitus, heart failure, stroke, and renal disease. About 1088212 hypertensive patients who received their first prescription for antihypertensive therapy between January 2021 to June 2021, were obtained from a database of Hangzhou Kang Sheng Health Consulting CO., Ltd. Calcium channel blockers (CCBs) and angiotensin II receptor blockers (ARBs) were the most common drugs prescribed for each comorbidity subgroup. Whereas diabetes mellitus or renal disease is a compelling indication for use of renin-angiotensin system inhibitors, CCBs were often administered in these subgroups. The treatment pattern for patients with coronary heart disease was closely similar to that for the overall patient population. Beta-blockers (BBs) were prescribed more frequently for patients with heart failure than for those with other comorbidities. Although antihypertensive drug prescription varied by comorbidity, pharmacological decisions were largely made under Chinese recommendations while physicians could select antihypertensive drugs based on the patients' comorbidities. However, educational initiatives are still necessary to inspire clinicians to better familiarize themselves with the guidelines and manage hypertension comorbid diseases.</p>","PeriodicalId":10333,"journal":{"name":"Clinical and Experimental Hypertension","volume":"44 3","pages":"240-248"},"PeriodicalIF":12.3,"publicationDate":"2022-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39777688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The relationship between mean platelet volume and resistant hypertension. 平均血小板体积与顽固性高血压的关系。
IF 12.3 4区 医学
Clinical and Experimental Hypertension Pub Date : 2022-04-03 Epub Date: 2022-01-03 DOI: 10.1080/10641963.2021.2022686
Halil Akın, Önder Bilge, Bünyamin Yavuz, Selçuk Özkan, Ferhat Işık
{"title":"The relationship between mean platelet volume and resistant hypertension.","authors":"Halil Akın,&nbsp;Önder Bilge,&nbsp;Bünyamin Yavuz,&nbsp;Selçuk Özkan,&nbsp;Ferhat Işık","doi":"10.1080/10641963.2021.2022686","DOIUrl":"https://doi.org/10.1080/10641963.2021.2022686","url":null,"abstract":"<p><strong>Objective: </strong>Resistant hypertension (RH) is associated with an increased risk of cardiovascular events.Mean platelet volume (MPV) has been shown to indicate platelet activation and is associated with increased cardiovascular disease risk. In our study, we aimed to evaluate the relationship between mean platelet volume and resistant hypertension.</p><p><strong>Method: </strong>A total of 279 patientswere included in our study and divided into three groups (GroupI: seventy-eight patients with resistant hypertension, group II: seventy-nine patients with controlled hypertension and group III: one-hundred-five patients without hypertension). Routine laboratory tests and ambulatory blood pressure measurement (ABPM) were followed up in all patients.</p><p><strong>Results: </strong>Of the patients in the study, 25% were female while 75% were male, and the mean age was 56.5 ± 11.8 years. The mean MPV values were found to be 9.34 ± 1.49 fL in the RHT group, 8.82 ± 0.83 fLin the controlled HT group, and 8.5 ± 0.85 fL in the normotensive individuals, and there was a significant correlation between the RHT group and the other groups (RHT versus controlled HT p1 = 0.008, RHT versus normotensive individuals p2 < 0,001). When we compared controlled HT and normotensive individuals, no significant relationship was found between MPV values (p3 = 0,157).</p><p><strong>Conclusion: </strong>The MPV value was found to be higher in resistant hypertensive patients compared to controlled hypertensive and normotensive patients. MPV values can be used to predict adverse cardiovascular events in RHT patients.</p>","PeriodicalId":10333,"journal":{"name":"Clinical and Experimental Hypertension","volume":"44 3","pages":"228-232"},"PeriodicalIF":12.3,"publicationDate":"2022-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39780070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Influence of FOXP3 gene polymorphisms on the risk of preeclampsia: a meta-analysis and a bioinformatic approach. FOXP3基因多态性对子痫前期风险的影响:荟萃分析和生物信息学方法
IF 12.3 4区 医学
Clinical and Experimental Hypertension Pub Date : 2022-04-03 Epub Date: 2022-01-11 DOI: 10.1080/10641963.2021.2022685
Mohammad Karimian, Saeedeh Ghazaey Zidanloo, Danial Jahantigh
{"title":"Influence of FOXP3 gene polymorphisms on the risk of preeclampsia: a meta-analysis and a bioinformatic approach.","authors":"Mohammad Karimian,&nbsp;Saeedeh Ghazaey Zidanloo,&nbsp;Danial Jahantigh","doi":"10.1080/10641963.2021.2022685","DOIUrl":"https://doi.org/10.1080/10641963.2021.2022685","url":null,"abstract":"<p><strong>Background and aim: </strong>Preeclampsia (PE), a multifactorial disorder, is the main cause of maternal mortality and morbidity. Genetic polymorphisms in key proteins involved in the immune system may change the risk of PE risk. In this study, we examined the association of two rs2232365 and rs3761548 common polymorphisms of the FOXP3 immune response gene with PE susceptibility by a meta-analysis which was followed by an in-silico analysis.</p><p><strong>Materials and methods: </strong>Through a systematic search in databases including PubMed, MEDLINE, Google Scholar, and Science Direct, we find eligible studies for meta-analysis. Some bioinformatics tools were used to detect the impact of rs2232365 and rs3761548 polymorphisms on the FOXP3 gene function.</p><p><strong>Results: </strong>Our data revealed that there is a significant association between rs3761548 polymorphism and decreased risk of PE. In addition, we observed a significant association between rs2232365 and increased risk of mild preeclampsia. Also, our bioinformatic analysis showed that both rs2232365 and rs3761548 polymorphisms could affect FOXP3 gene function.</p><p><strong>Conclusion: </strong>Based on our findings, the rs3761548 genetic variation could be a protective factor against PE risk. While the rs2232365 polymorphism may be a genetic risk factor for mild preeclampsia. Therefore, as a preliminary study, these genetic variations could be considered molecular biomarkers for PE disorder.</p>","PeriodicalId":10333,"journal":{"name":"Clinical and Experimental Hypertension","volume":"44 3","pages":"280-290"},"PeriodicalIF":12.3,"publicationDate":"2022-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39809649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Effect of prior beta-blocker use on in-hospital atrial fibrillation development in patients with ST-elevation myocardial infarction. 既往使用受体阻滞剂对st段抬高型心肌梗死患者住院房颤发展的影响
IF 12.3 4区 医学
Clinical and Experimental Hypertension Pub Date : 2022-04-03 Epub Date: 2022-01-30 DOI: 10.1080/10641963.2022.2029473
Fatih Kahraman, Akif Arslan, Abdullah Dogan, Yasin Turker, Serdar Guler
{"title":"Effect of prior beta-blocker use on in-hospital atrial fibrillation development in patients with ST-elevation myocardial infarction.","authors":"Fatih Kahraman,&nbsp;Akif Arslan,&nbsp;Abdullah Dogan,&nbsp;Yasin Turker,&nbsp;Serdar Guler","doi":"10.1080/10641963.2022.2029473","DOIUrl":"https://doi.org/10.1080/10641963.2022.2029473","url":null,"abstract":"<p><strong>Background and aim: </strong>There are conflicting results about the early administration of beta-blockers (bb) on in-hospital mortality and arrhythmias. Here, we wanted to investigate the effects of chronic bb use on in-hospital Atrial Fibrillation (AF) development in ST-Elevation Myocardial Infarction (STEMI) patients.</p><p><strong>Materials and methods: </strong>A total of 814 consecutive patients with STEMI were included in the study. They were divided into two groups according to whether they are using bb on admission or not. They were followed for AF development in-hospital and predictors of AF were determined by multivariable logistic regression analysis.</p><p><strong>Results: </strong>Of the 814 patients, 103 (12.67%) patients were already using bb, while 711 (87.3%) were not. There were no significant differences in the frequency of AF development [3 (%2.9) vs 30 (%4.2), p = .788] between the groups. Multivariable logistic regression analysis showed that left atrial (LA) diameter is the only independent predictor of in-hospital AF development.</p><p><strong>Conclusions: </strong>Our study showed that chronic bb use does not have an effect on in-hospital AF development in STEMI patients. Nevertheless, LA diameter was found to be an independent predictor of AF.</p>","PeriodicalId":10333,"journal":{"name":"Clinical and Experimental Hypertension","volume":"44 3","pages":"263-267"},"PeriodicalIF":12.3,"publicationDate":"2022-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39874077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of allisartan on blood pressure and left ventricular hypertrophy through Kv1.5 channels in hypertensive rats. 艾利沙坦通过Kv1.5通道对高血压大鼠血压及左心室肥厚的影响。
IF 12.3 4区 医学
Clinical and Experimental Hypertension Pub Date : 2022-04-03 Epub Date: 2022-01-11 DOI: 10.1080/10641963.2021.2018597
Chunfang Xu, Ziying Zhao, Wang Yuan, Zhao Fengping, Yan Zhiqiang, Zhang Xiaoqin
{"title":"Effect of allisartan on blood pressure and left ventricular hypertrophy through Kv1.5 channels in hypertensive rats.","authors":"Chunfang Xu,&nbsp;Ziying Zhao,&nbsp;Wang Yuan,&nbsp;Zhao Fengping,&nbsp;Yan Zhiqiang,&nbsp;Zhang Xiaoqin","doi":"10.1080/10641963.2021.2018597","DOIUrl":"https://doi.org/10.1080/10641963.2021.2018597","url":null,"abstract":"<p><strong>Background: </strong>The objective of the present work was to study the anti-hypertensive effect of allisartan on blood pressure (BP) and in facilitating left ventricular remodeling through voltage-gated potassium channels (Kv) 1.5 channels.</p><p><strong>Methods: </strong>A total of 30 SD rats were randomly divided into sham operation group, hypertension control group, and allisartan treatment group. Hypertension was induced by renal artery stenosis. The animals of treatment group were administered with allisartan once a day at a dose of 30 mg/kg body weight through an oral gavage for 4 weeks. The heart function of animals post 4 weeks of treatment was evaluated by echocardiography, and the degree of ventricular hypertrophy and cardiomyocyte hypertrophy were evaluated by histomorphology. The expression of Kv1.5 is detected by real-time quantitative polymerase chain reaction while Western blotting was used to detect the protein expression.</p><p><strong>Results: </strong>Four weeks after renal artery stenosis, a significant difference was observed in the whole heart ratio, left heart ratio, and cardiomyocyte area between allisartan treatment group and the hypertension control group (<i>P</i>< .01). A significant decrease in BP of allisartan treatment group compared to hypertension control group (<i>P</i>< .01) was observed. The expression of Kv1.5 mRNA was increased significantly (<i>P</i>< .01) in allisartan treatment group compared to hypertension control group. Western blot analysis also confirmed the increased expression of Kv1.5 channel.</p><p><strong>Conclusion: </strong>The results showed that allisartan lowers BP and improves left ventricular remodeling through increased expression of Kv1.5 mRNA.</p>","PeriodicalId":10333,"journal":{"name":"Clinical and Experimental Hypertension","volume":"44 3","pages":"199-207"},"PeriodicalIF":12.3,"publicationDate":"2022-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39810047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信